Annual Results Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
EQUITY AND LIABILITIES
No of Months
12
12
Share Capital
12.55
10.94
Share Warrants & Outstandings
Total Reserve
1,137.18
803.96
Shareholder's Funds
1,149.73
814.89
Minority Interest
0.00
0.00
Long-Term Borrowings
68.41
253.01
Secured Loans
68.41
253.01
Unsecured Loans
0.00
0.00
Deferred Tax Assets / Liabilities
5.81
21.99
Other Long Term Liabilities
7.84
4.09
Long Term Trade Payables
0.00
0.00
Long Term Provisions
21.57
13.25
Total Non-Current Liabilities
103.64
292.35
Current Liabilities
Trade Payables
138.33
88.50
Other Current Liabilities
63.15
92.06
Short Term Borrowings
319.50
287.91
Short Term Provisions
6.59
4.12
Total Current Liabilities
527.57
472.60
Total Liabilities
1,780.79
1,579.65
ASSETS
Non-Current Assets
0.00
0.00
Gross Block
1,363.75
630.16
Less: Accumulated Depreciation
279.37
228.62
Less : Impairment of Assets
0.00
0.00
Net Block
1,084.39
401.54
Lease Adjustment
0.00
0.00
Capital Work in Progress
64.48
568.16
Intangible assets under development
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
Assets in transit
0.00
0.00
Non Current Investments
40.42
37.92
Long Term Loans & Advances
100.97
77.83
Other Non Current Assets
4.99
1.35
Total Non-Current Assets
1,295.25
1,086.79
Current Assets Loans & Advances
Current Investments
0.00
0.00
Inventories
236.88
261.45
Sundry Debtors
197.60
175.65
Cash and Bank
10.12
26.47
Other Current Assets
19.25
20.93
Short Term Loans and Advances
21.69
8.35
Total Current Assets
485.54
492.86
Net Current Assets (Including Current Investments)
-42.02
20.26
Total Current Assets Excluding Current Investments
485.54
492.86
Miscellaneous Expenses not written off
0.00
0.00
Total Assets
1,780.79
1,579.65
Contingent Liabilities
0.00
0.00
Total Debt
387.91
540.92
Book Value per share (adjusted)
0
149.03
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -28.29% vs NA in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 91.69% vs NA in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is 18.48% vs NA in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 6.59% vs NA in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is -1.49% vs NA in Mar 2025
Compare Balance Sheet Results of Symbiotec Pharma
Figures in Cr
Consolidated - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.55
23.00
-10.45
-45.43%
Share Warrants & Outstandings
Total Reserve
1,137.18
768.10
369.08
48.05%
Shareholder's Funds
1,149.73
860.60
289.13
33.60%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
68.41
0.00
68.41
0.00%
Secured Loans
68.41
0.00
68.41
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
5.81
-0.10
5.91
5,910.00%
Other Long Term Liabilities
7.84
32.00
-24.16
-75.50%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
21.57
0.00
21.57
0.00%
Total Non-Current Liabilities
103.64
31.90
71.74
224.89%
Current Liabilities
Trade Payables
138.33
406.30
-267.97
-65.95%
Other Current Liabilities
63.15
194.40
-131.25
-67.52%
Short Term Borrowings
319.50
0.00
319.50
0.00%
Short Term Provisions
6.59
118.50
-111.91
-94.44%
Total Current Liabilities
527.57
719.20
-191.63
-26.64%
Total Liabilities
1,780.79
1,611.70
169.09
10.49%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1,363.75
505.40
858.35
169.84%
Less: Accumulated Depreciation
279.37
248.30
31.07
12.51%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1,084.39
257.10
827.29
321.78%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
64.48
18.10
46.38
256.24%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
40.42
0.00
40.42
0.00%
Long Term Loans & Advances
100.97
147.40
-46.43
-31.50%
Other Non Current Assets
4.99
6.90
-1.91
-27.68%
Total Non-Current Assets
1,295.25
484.90
810.35
167.12%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
236.88
499.80
-262.92
-52.61%
Sundry Debtors
197.60
230.00
-32.40
-14.09%
Cash and Bank
10.12
294.80
-284.68
-96.57%
Other Current Assets
19.25
57.20
-37.95
-66.35%
Short Term Loans and Advances
21.69
45.00
-23.31
-51.80%
Total Current Assets
485.54
1,126.80
-641.26
-56.91%
Net Current Assets (Including Current Investments)
-42.02
407.60
-449.62
-110.31%
Total Current Assets Excluding Current Investments
485.54
1,126.80
-641.26
-56.91%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,780.79
1,611.70
169.09
10.49%
Contingent Liabilities
0.00
291.10
-291.10
-100.00%
Total Debt
387.91
0.00
387.91
0.00%
Book Value per share (adjusted)
0.00
374.17
-374.17
-100.00%
Annual - Borrowings
Borrowings 387.91 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -28.29% vs NA in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 7.84 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 91.69% vs NA in Mar 2025
Annual - Fixed Assets
Fixed Assets 1,148.87 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 18.48% vs NA in Mar 2025
Annual - Investments
Investments 40.42 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 6.59% vs NA in Mar 2025
Annual - Current Assets
Current Assets 485.54 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -1.49% vs NA in Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
